THE NEW POSSIBILITY FOR BODY CONTROL ?

Researchers are increasingly examining retatrutide, a promising drug developed by Eli Lilly, as a potential breakthrough in weight management. Distinct from many previous approaches, retatrutide is a double -action compound targeting simultaneously GLP-1 and GIP, chemicals that influence appetite